vania-janet/multiturn-rag-retrieval-data huggingface dataset:
COVID-19 Overview and Infection Prevention and Control Priorities in non-U.S. Healthcare Settings | CDC
The droplets that contain the SARS-CoV-2 virus are released when someone with COVID-19 sneezes, coughs, or talks. Infectious droplets can land in the mouths or noses of people who are nearby or possibly be inhaled into the lungs. A physical distance of at least 1 meter (3 ft) between persons is recommended by the WHO to avoid infection,1 whereas CDC recommends maintaining a physical distance of at least 1.8 meters (6ft) between persons. Respiratory droplets can land on hands, objects, or surfaces around the person when they cough or talk, and people can then become infected with COVID-19 from touching hands, objects or surfaces with droplets and then touching their eyes, nose, or mouth. Additionally, transmission can occur from those with mild symptoms or from those who do not feel ill.
There are certain circumstances that can increase the risk of infection for COVID-19 such as poorly ventilated space. In indoor spaces with poor ventilation, the concentration of virus particles is often higher than outdoors.2,3 Other factors that are associated with increased COVID-19 risk include prolonged exposure to those infected with COVID-19, close contact with infected persons, and any other activity that leads to exposure to a greater amount of respiratory droplets and particles.
Symptoms
A wide range of symptoms for COVID-19 have been reported.4 These symptoms include:

Fever or chills
Cough
Muscle or body aches
Anorexia
Sore throat
Nasal congestion or runny nose
Headache
Diarrhea
Nausea
Shortness of breath or difficulty breathing
Loss of smell or taste

The estimated incubation period is between 2 and 14 days with a median of 5 days. It is important to note that some people become infected and do not develop any symptoms or feel ill.
People at Higher Risk for Severe Illness
COVID-19 is a relatively new disease; therefore, additional risk factors for severe COVID-19 may continue to be identified. In some cases, people who get COVID-19 can develop severe complications, including difficulty breathing, causing a need for hospitalization and intensive care. 5 These severe complications often lead to death.
Standard Operating Procedure (SOP) for Triage of Suspected COVID-19 Patients in non-US Healthcare Settings: Early Identification and Prevention of Transmission during Triage | CDC
This area should have benches, stalls or chairs separated by at least one meter distance based on WHO recommendations (CDC recommends 6 feet or 1.8 meters). The waiting areas should have dedicated toilets and hand hygiene stations. Patients who are suspected to have COVID-19 should not be mixed with COVID-19 confirmed patients in isolation areas.3
Post clear signs informing patients of the location of waiting areas for suspected COVID-19. Train the registration desk staff to direct patients immediately to these areas after registration.
Provide paper tissues, alcohol-based hand rub, and trash bins with lids for the separate COVID-19 waiting area.
Develop a process to reduce the amount of time patients are in the COVID-19 waiting area, which may include:

Allocation of additional staff to triage patients suspected of COVID-19
Setting up a notification system that allows patients to wait in a personal vehicle or outside of the facility (if medically appropriate) in a place where social distance can be maintained and they can be easily notified by phone or other remote methods when it is their turn to be evaluated.

Triage process

A medical mask* should be given to patients with respiratory symptoms as soon as they get to the facility if they do not already have one. All patients in the separate COVID-19 waiting area should wear a medical mask or a well-fitting form of source control.
In areas of known or suspected community or cluster SARS-CoV-2 transmission, all persons should wear masks within the health facility4.
If medical masks are not available, provide an option that is equivalent to what is recommended for people in the community in the country. For example, a cloth mask can be used as source control if medical mask is not available. Exercise caution as these items will become contaminated and can serve as a source of transmission to other patients or family members. WHO’s guidance should be followed by patients and family members to clean these items.
Use a standardized triage algorithm to immediately isolate/separate patients at high risk** for having COVID-19 in single-person rooms with doors closed or designated COVID-19 waiting areas.
COVID-19 Overview and Infection Prevention and Control Priorities in non-U.S. Healthcare Settings | CDC
IPC is a critical part of health system strengthening and must be a priority to protect patients and healthcare workers. In the context of COVID-19, the IPC goal is to support the maintenance of essential healthcare services by containing and preventing COVID-19 transmission within healthcare facilities to keep patients and healthcare workers healthy and safe.
COVID-19 IPC Priorities

Rapid identification of suspect cases

Screening/triage at initial healthcare facility encounter and rapid implementation of source control
Limiting the entry of healthcare workers and/or visitors with suspected or confirmed COVID-19

Immediate isolation and referral for testing

Group patients with suspected or confirmed COVID-19 separately
Test all suspected patients for COVID-19

Safe clinical management

Immediate identification of inpatients and healthcare workers with suspected COVID-19

Adherence to IPC practices

Appropriate use of personal protective equipment (PPE)
Unvaccinated healthcare workers, patients, and visitors should be offered resources and counseled about the importance of vaccination.

COVID-19 IPC in the context of vaccination delivery
As safe and effective COVID-19 vaccines continue to be delivered, there are certain recommendations and principles that should be implemented and considered for vaccine administration. Consultations and consensus between WHO, the United Nations Children’s Fund (UNICEF), and the ad hoc WHO COVID-19 IPC Guidance Development Group have led to the development of a document that outlines key IPC principles and recommended proper precautions for safe administration of COVID-19 vaccines. Consult the Infection prevention and control (IPC) principles and procedures for COVID-19 vaccination activities document when preparing for vaccine deployment. 10
The key IPC principles for COVID-19 vaccine deployment set out in the document include:

Applying standard precautions during any vaccination activity
Performing additional IPC precautions like mask use in the context of the COVID-19 pandemic
Providing healthcare workers with specific training and providing the public with targeted information regarding IPC measures for safe vaccine delivery
Having a clean, hygienic, and well-ventilated environment with appropriate waste management, and adequate spaces that facilitate best IPC practices like physical distancing
Información para entender cómo actúan las vacunas contra el COVID-19 | CDC
Actualizado el 22 de sep. del 2023 

English | Otros idiomas 

Imprimir

Menos

Páginas relacionadas

Lo que necesita saber
Las vacunas contra el COVID-19 ayudan a nuestro organismo a desarrollar inmunidad contra el virus que causa el COVID-19 sin que para ello tengamos que contraer la enfermedad.
Las diferentes vacunas contra el COVID-19 pueden actuar de manera diferente en nuestros organismos, pero todas protegen contra el virus que causa el COVID-19.
Ninguna de las vacunas contra el COVID-19 pueden provocarle COVID-19.
Lanzar vacunas nuevas al público supone varios pasos, y se deben seguir todos para garantizar que sean seguras y efectivas antes de ponerlas a disposición para su uso.

Cómo actúan las vacunas contra el COVID-19
Las vacunas contra el COVID-19 ayudan a nuestro organismo a desarrollar inmunidad contra el virus que causa el COVID-19 sin que para ello tengamos que contraer la enfermedad.

Los diferentes tipos de vacunas actúan de diferentes formas para brindar protección. Pero, con todos los tipos de vacunas el organismo se queda con un suministro de linfocitos T de "memoria", además de linfocitos B que recordarán cómo combatir ese virus en el futuro.
Por lo general, después de la vacunación el organismo demora algunas semanas en producir linfocitos T y linfocitos B.
Post-COVID Conditions: Information for Healthcare Providers
Open Forum Infect Dis. 2020 Oct;7(10):ofaa420. doi:10.1093/ofid/ofaa420
Logue JK, Franko NM, McCulloch DJ, et al. Sequelae in Adults at 6 Months After COVID-19 Infection. JAMA Netw Open. 2021 Feb 1;4(2):e210830. doi:10.1001/jamanetworkopen.2021.0830
del Rio C, Collins LF, Malani P. Long-term health consequences of COVID-19. JAMA.  2020. doi:10.1001/jama.2020.19719
Taquet M, Geddes JR, Husain M, et al. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021 May;8(5):416-427. doi:10.1016/S2215-0366(21)00084-5
Barker-Davies RM, O’Sullivan O, Senaratne KPP, et al. The Stanford Hall consensus statement for Post-COVID-19 rehabilitation. Br J Sports Med. 2020 Aug;54(16):949-959. doi:10.1136/bjsports-2020-102596
Li Z, Zheng C, Duan C, et al. Rehabilitation needs of the first cohort of Post-acute COVID-19 patients in Hubei, China. Eur J Phys Rehabil Med. 2020 Jun;56(3):339-344. doi: 10.23736/S1973-9087.20.06298-X. PMID: 32672029. doi:10.23736/s1973-9087.20.06298-x
Daynes E, Gerlis C, Chaplin E, et al.
Sobre Las Vacunas Contra El COVID-19 | Veterans Affairs
En los Estados Unidos cientos de millones de personas han recibido con seguridad las vacunas contra el COVID-19.No hay cura para el COVID-19 en este momento. Existen tratamientos para el COVID-19. Sin embargo, el riesgo de enfermedad grave y muerte sigue siendo alto en ciertos grupos de personas. Hable con su proveedor de atención médica antes de tomar cualquier medicamento para prevenir o tratar el COVID-19.Obtenga más información sobre los tratamientos contra el COVID-19 en el sitio web de los CDCAlgunas personas informan de los efectos a largo plazo del COVID-19. La mayoría de las personas mejoran en semanas. Pero algunas personas tienen efectos que duran más tiempo. Estos efectos pueden incluir síntomas como mareos, depresión o sensación de mucho cansancio. También pueden incluir efectos en órganos vitales como el corazón o los pulmones. Dichos efectos pueden ocurrir incluso después de una enfermedad leve.Aprende más sobre los efectos a largo plazo del COVID-19 en el sitio web de los CDCCuando está al día en sus vacunas, usted puedes hacer más cosas. Este incluye visitando con familia y amigos o yendo a diferentes actividades. Manteniéndose actualizado con las vacunas minimiza el riesgo de enfermarse gravemente o de la muerte por el COVID-19.
Coronavirus Disease 2019 (COVID-19) | CDC
For Health ProfessionalsHealthcare WorkersHealth DepartmentsLaboratory Personnel
For Health ProfessionalsHealthcare WorkersHealth DepartmentsLaboratory Personnel

Languages

Español

Other Languages

Languages

Español

Other Languages

 

	Last Updated Mar. 15, 2024	Source: 	National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases

Facebook
Twitter
LinkedIn
Syndicate

 

homeCOVID-19About COVID-19plus iconVariantsHow COVID-19 SpreadsReinfectionAnimals and COVID-19Health EquitySymptomsTestingMedical ConditionsPreventionplus iconMasksplus iconTypes of Masks and RespiratorsUse and Care of MasksHow to Use Your N95 RespiratorVentilationplus iconHome VentilationImproving Ventilation In BuildingsFacility Cleaning & Ventilationplus iconUpper-Room Ultraviolet Germicidal IrradiationVentilation in BuildingsSchool Ventilation ToolVaccinesplus iconStay Up to Date with VaccinesOverview of COVID-19 VaccinesHow COVID-19 Vaccines WorkYour Vaccinationplus iconWhen Getting Your VaccineSpecific Groups of PeopleSafety of COVID-19 Vaccinesplus iconAllergic ReactionsVaccine Safety in Children & TeensMyocarditis and PericarditisInvestigating MyocarditisReported Adverse EventsCOVID-19 Vaccine Effectivenessplus iconVaccine Effectiveness StudiesAbout COVID-19 Vaccinesplus iconFrequently Asked QuestionsBenefits of Getting VaccinatedMyths & FactsTreatments & MedicationsLong COVIDplus iconCaring for People with Long COVIDPatient Appointment TipsData & Surveillanceplus iconHospitalization Surveillance Network COVID-NETplus iconCOVID-NET DashboardCOVID-NET Overview
Covid-19 Vaccines


My COVID-19 Vaccine RecordLeft imageMy COVID-19 Vaccine Recordhttp://cdph-default/Programs/CID/DCDC/PublishingImages/COVID-19/Woman-with-phone-square.png, Woman smiling as she uses her mobile phone.1<p><span data-contrast="none" lang="EN-US">​​</span><span data-ccp-props="{"201341983":0,"335559739":160,"335559740":259}">If you were vaccinated in California, you can access a digital copy of your vaccination record. ​</span></p><p><span data-ccp-props="{"201341983":0,"335559739":160,"335559740":259}"></span><a href="https://myturn.ca.gov/">Visit My Turn</a>​​<br></p>https://myvaccinerecord.cdph.ca.gov/, Get your COVID-19 Vaccine Record

 
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.

 
Post-Vaccine COVID-19 Cases Right imagePost-Vaccine COVID-19 Cases http://cdph-default/Programs/CID/DCDC/PublishingImages/COVID-19/man-looks-at-thermometer-under-blanket-464x480.png, Man looks at a thermometer as he lays under a blanket1<p>​​Post-vaccination cases are individuals who are fully vaccinated and have a positive SARS-CoV-2 molecular (e.g. PCR) test 14 days or more after they have completed their full one-dose or two-dose COVID-19 vaccination series.
Surveillance & Data Analytics
To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).
National Notifiable Diseases Surveillance System (NNDSS)
Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).
National Syndromic Surveillance Program (NSSP)
Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.
*Requires an account with NSSP to access*
NSSP for syndromic surveillance
Includes access to the RShiny app
Electronic Surveillance System for the Early Notification of Community-based Epidemics (ESSENCE)
For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).

Resources from other organizations
Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement, actual or implied, of the tools. Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.
Private sector, non-governmental organizations and academia
Various other organizations are also supporting this critical effort by providing:

Google Community Mobility Reports
Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.


	Last Updated Mar. 26, 2021	Source: 	National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases

Facebook
Twitter
LinkedIn
Syndicate
COVID-19 Guidance Repository | Department of Health
Updated December 20, 2023 - Revised information on the infection prevention and control recommendations that Adult Care Facilities in NYS should follow during the COVID-19...

Download about Infection Prevention and Control Recommendations for Adult Care Facilities (ACFs) to Reduce the Risk of COVID-19

Image of a report.

 
 Current, 
 
 Guidance
 

 Home Care and Hospice Infection Prevention and Control Frequently...
 

 November 17, 2023 - Applicable to entities regulated under Articles 36 and 40 of the Public Health Law

Download about Home Care and Hospice Infection Prevention and Control Frequently Asked Questions

Image of a report.

 
 Guidance, 
 
 Current
 

 Healthcare Worker Vaccine Mandate Guidance Update
 

 May 24, 2023 - The NYS Dept. of Health will cease citing providers for failing to comply with requirements of 10 NYCRR Section 2.61.

Download about Healthcare Worker Vaccine Mandate Guidance Update

Image of a report.

 
 Guidance, 
 
 Current
 

 FAQs for Serial (Repeat) Testing Requirements 
 

 March 20, 2023: Frequently Asked Questions (FAQs) - U.S. Food and Drug Administration (FDA) Revisions to COVID-19 Antigen Tests: Requirements for Serial (Repeat) Testing

Download about FAQs for Serial (Repeat) Testing Requirements 

Image of a report.

 
 Guidance, 
 
 Current
 

 Update: Nursing Home Visitor Testing and Screening for COVID-19
 

 March 17, 2023: NYSDOH is fully aligning with the Centers for Medicare and Medicaid Services (CMS) regarding nursing home COVID-19 screening and visitor testing.

Download about Update: Nursing Home Visitor Testing and Screening for COVID-19

Image of a report.

 
 Current
 

 Revised Case Definition: Multi-system Inflammatory Syndrome in Ch...
 

 February 24, 2023 - Effective January 1, 2023, NYSDOH implemented a revised surveillance case definition for multi-system inflammatory syndrome in children (MIS-C) associated with coronavirus disease...

Download about Revised Case Definition: Multi-system Inflammatory Syndrome in Children (MIS-C) 

Image of a report.

 
 Guidance, 
 
 Current
 

 Elective Surgery Pre-Procedure Testing
Coronavirus Disease 2019 (COVID-19) | CDC
Coronavirus Disease 2019 (COVID-19) | CDC
 
 

 

 

Skip directly to site content
Skip directly to search

EspaÃ±ol | 
Other Languages

An official website of the United States government Here's how you know 

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

 

Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People

Ã

Submit

HOME
 COVID-19

 

 

 

Minus

Related Pages

COVID-19 Vaccines
COVID-19 vaccines are safe, effective, and free. Everyone 6 months and older can get an updated COVID-19 vaccine. Learn more.

Highlights

How to Protect Yourself and Others 
People with Certain Medical Conditions 
Ventilation in Buildings

COVID-19 Vaccines
COVID-19 vaccines are safe, effective, and free. Everyone 6 months and older can get an updated COVID-19 vaccine. Learn more.

Highlights

How to Protect Yourself and Others 
People with Certain Medical Conditions 
Ventilation in Buildings

Symptoms of COVID-19People may experience sudden fever or chills, cough, shortness of breath, loss of taste or smell, and other symptoms.

Testing for COVID-19Use viral tests like PCR or rapid at-home tests to determine if you are sick with COVID-19. Learn how to get tested.

Treatments and MedicationsAntiviral medications are available to treat mild to moderate COVID-19. Start treatment as soon as you develop symptoms.

Get the Latest on COVID-19, Flu, and RSVLearn more about all three of these respiratory viruses, who is most at risk, and how they are affecting your state right now. You can use some of the same strategies to protect yourself from all three viruses.
Get the Latest on COVID-19, Flu, and RSV
Post-COVID Conditions: Information for Healthcare Providers
A prospective observational study. medRxiv. 2021 March 11; 21253225. Accessed at: https://www.medrxiv.org/content/10.1101/2021.03.11.21253225v2
Santoli JM, Lindley MC, DeSilva MB, et al. Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration – United States, 2020. MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):591-593.
Choutka, J., Jansari, V., Hornig, M. et al. Unexplained Post-acute infection syndromes. Nat Med 28,911–923 (2022). https://doi.org/10.1038/s41591-022-01810-6
Tenforde MW, Devine OJ, Reese HE, et al. Point Prevalence Estimates of Activity-Limiting Long-Term Symptoms among U.S. Adults ≥1 Month After Reported SARS-CoV-2 Infection, November 1, 2021, The Journal of Infectious Diseases, 2022;, jiac281, https://doi.org/10.1093/infdis/jiac281
A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection: Illness Beyond Acute Infection and Public Health Implications | Cardiology | JAMA | JAMA Network
Toward Understanding COVID-19 Recovery: National Institutes of Health Workshop on Postacute COVID-19 | Annals of Internal Medicine (acpjournals.org)
A clinical case definition of Post COVID-19 condition by a Delphi consensus, 6 October 2021 (who.int)
Early clues regarding the pathogenesis of long-COVID: Trends in Immunology (cell.com)


	Last Updated Feb. 6, 2024	Source: 	National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases

Facebook
Twitter
LinkedIn
Syndicate
Tungkol Sa Bakuna Laban Sa COVID-19 | Veterans Affairs
Tinuturuan ng mga bakuna ang inyong mga selula kung paano gumawa ng protina (protein) na magpapagana sa isang immune response. Pagkatapos, maghihiwal-hiwalay ang inyong mga selula at aalisin ang mRNA kapag naisagawa na ng mga ito ang lahat ng tagubilin.

 Hindi ka magkakaroon ng COVID-19 kung mababakunahan laban sa COVID-19 
 

Ginagamit ng mga kasalukuyang bakuna laban sa COVID-19 at ng mga bakunang ginagawa pa, ang isa sa mga paraang ito:Ang isang virus na hindi aktiboAng isang parte ng virus na hindi nakakasamaAng isang gene mula sa virusWala sa mga ito ang nagdudulot ng COVID-19Mas alamin kung paano gumagana ang mga bakuna laban sa COVID-19 sa website ng CDC (sa English)

 Pinoprotektuhan kayo, ang inyong pamilya at ang inyong komunidad ng mga bakuna 
 

Paano kayo pinoprotektuhan ng mga bakunaTinutulungan ng mga bakuna na sanayin ang natural na immune system ng inyong katawan na kilalanin at labanan ang isang espesipikong sakit, sa pamamagitan ng pag-uudyok ng reaksyon sa virus na nagdudulot ng sakit.Kapag nakapasok ang isang virus sa inyong katawan sa unang pagkakataon, bumubuo ng depensa ang inyong immune system. Kasama dito ang paggawa ng antibodies na tumutulong na patayin o nyutralisahin ang virus.
Información para entender cómo actúan las vacunas contra el COVID-19 | CDC
correo_electrónico_03Reciba actualizaciones por correo electrónico Para recibir actualizaciones del COVID-19, ingrese su dirección de correo electrónico: Correo electrónico Información Enviar 

Acerca de los CDC
Contáctenos
800-232-4636

Facebook
Twitter
Instagram
LinkedIn
Youtube
Pinterest
Snapchat

 COMUNÍQUESE CON CDC 

Contáctenos

Llame al 800-232-4636

Envíenos un correo electrónico

 ACERCA DE LOS CDC 

Acerca de los CDC
Empleos
Financiamiento

 POLÍTICAS 

Accesibilidad
Enlaces externos
Privacidad
Políticas
Ley No Fear
Ley FOIA
OIG
Aviso de no discriminación
Política de divulgación de vulnerabilidad

 CONÉCTESE CON NOSOTROS 

Facebook
Twitter
Instagram
LinkedIn

Youtube
Pinterest
Snapchat

 IDIOMAS 

Español
繁體中文
Tiếng Việt
한국어
Tagalog
Русский
العربية
Kreyòl Ayisyen
Français
Polski
Português
Italiano
Deutsch
日本語
فارسی
English

Español
繁體中文
Tiếng Việt
한국어
Tagalog
Русский
العربية
Kreyòl Ayisyen
Français
Polski
Português
Italiano
Deutsch
日本語
فارسی
English

Accesibilidad
Enlaces externos
Privacidad